StockData
Cytokinetics Inc logo

Cytokinetics Inc (CYTK) stock

CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$51.65−1.52 (-2.86%)

Close on Nov 17, 2026Market cap $7.18BP/E –Yield –

Cytokinetics total assets

Total assets on the balance sheet at the end of each period.

Cytokinetics's total assets was $1.92B at Jun 30, 2026. For fiscal 2025 it was $1.42B, up 1.6% from the year before. Over ten years it grew 28.6% a year on average. The highest annual figure on record is $1.42B in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.42B+1.6%
FY2024Dec 31, 2024$1.40B+70.0%
FY2023Dec 31, 2023$824.32M-18.8%
FY2022Dec 31, 2022$1.01B+20.6%
FY2021Dec 31, 2021$841.32M+57.6%
FY2020Dec 31, 2020$533.80M+84.2%
FY2019Dec 31, 2019$289.81M+37.2%
FY2018Dec 31, 2018$211.18M-28.4%
FY2017Dec 31, 2017$294.81M+73.3%
FY2016Dec 31, 2016$170.14M+47.6%
FY2015Dec 31, 2015$115.24M-13.3%
FY2014Dec 31, 2014$132.97M+59.8%
FY2013Dec 31, 2013$83.19M+7.3%
FY2012Dec 31, 2012$77.55M+47.0%
FY2011Dec 31, 2011$52.77M-32.3%
FY2010Dec 31, 2010$77.99M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.92B+57.0%
Q1 FY2026Mar 31, 2026$1.27B+0.7%
Q4 FY2025Dec 31, 2025$1.42B+1.6%
Q3 FY2025Sep 30, 2025$1.44B+0.0%
Q2 FY2025Jun 30, 2025$1.23B-19.6%
Q1 FY2025Mar 31, 2025$1.26B+56.4%
Q4 FY2024Dec 31, 2024$1.40B+70.0%
Q3 FY2024Sep 30, 2024$1.44B+93.9%
Q2 FY2024Jun 30, 2024$1.52B+95.4%
Q1 FY2024Mar 31, 2024$808.08M-9.2%
Q4 FY2023Dec 31, 2023$824.32M-18.8%
Q3 FY2023Sep 30, 2023$740.61M-31.2%
Q2 FY2023Jun 30, 2023$779.90M+1.1%
Q1 FY2023Mar 31, 2023$889.82M+3.9%
Q4 FY2022Dec 31, 2022$1.01B+20.6%
Q3 FY2022Sep 30, 2022$1.08B+30.0%
Q2 FY2022Jun 30, 2022$771.72M+36.8%
Q1 FY2022Mar 31, 2022$856.25M+48.4%
Q4 FY2021Dec 31, 2021$841.32M+57.6%
Q3 FY2021Sep 30, 2021$827.54M+74.5%
Q2 FY2021Jun 30, 2021$564.30M+142.7%
Q1 FY2021Mar 31, 2021$577.06M+124.9%
Q4 FY2020Dec 31, 2020$533.80M+84.2%
Q3 FY2020Sep 30, 2020$474.11M+153.0%
Q2 FY2020Jun 30, 2020$232.50M+17.3%
Q1 FY2020Mar 31, 2020$256.58M+29.2%
Q4 FY2019Dec 31, 2019$289.81M+37.2%
Q3 FY2019Sep 30, 2019$187.39M-18.6%
Q2 FY2019Jun 30, 2019$198.22M-19.8%
Q1 FY2019Mar 31, 2019$198.61M-29.0%
Q4 FY2018Dec 31, 2018$211.18M-28.4%
Q3 FY2018Sep 30, 2018$230.28M-29.4%
Q2 FY2018Jun 30, 2018$247.24M-27.4%
Q1 FY2018Mar 31, 2018$279.93M+5.5%
Q4 FY2017Dec 31, 2017$294.81M+73.3%
Q3 FY2017Sep 30, 2017$326.31M+106.3%
Q2 FY2017Jun 30, 2017$340.63M–
Q1 FY2017Mar 31, 2017$265.37M–
Q4 FY2016Dec 31, 2016$170.14M–
Q3 FY2016Sep 30, 2016$158.17M–

More Cytokinetics figures

See a number that looks wrong?